Počet záznamov: 1
natalizumab
SYS d000069442 LBL 00000nx^^^2200181-^^45^^ 005 20240119201427.8 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a natalizumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2016 (2002) $8 eng 330 1-
$a A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE. $8 eng 550 $3 sllk_un_auth*d039441 $Y Integrin alpha4 $5 F $a integrín alfa4 550 $3 sllk_un_auth*d039441 $Y Integrin alpha4 $5 B $a integrín alfa4 686 $a D12.776.124.486.485.114.224.060.813 686 $a D12.776.124.790.651.114.224.060.813 686 $a D12.776.377.715.548.114.224.200.813 750 $a Natalizumab $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160209 980 $x M
Počet záznamov: 1